• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

New method for sensitive in situ telomerase assay and it's application.

Research Project

Project/Area Number 12672255
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionTokyo women's Medical university

Principal Investigator

YAMADA Osamu  Tokyo women's Medical university, Medical Research Institute, Assistant professor, 医学部, 助教授 (30167712)

Project Period (FY) 2000 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2003: ¥200,000 (Direct Cost: ¥200,000)
Fiscal Year 2002: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2001: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2000: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsTelomere / Telomerase / in situ / Diagnosis / Cancer
Research Abstract

The introduction of the telomeric repeat amplification protocol assay means telomerase can be detected in small samples from almost all types of tumors. However it is not known whether all or only a small subset of tumor cells have telomerase activity. Activated lymphocytes in normal tissue may give false positive results. We used in cell telomeric repeat synthesis and PCR in situ with in situ hybridization to document telomerase activity. The intracellular amplification of telomere sequences was achieved with single primer pairs and the PCR products were detected by subsequent in situ hybridization using digoxigenin-labeled oligonucleotide probes specific for the amplification products.
The validity and specificity of our methods were confirmed as follows. (1)Without TS primer, no signal was detected. (2)Without Taq DNA polymerase, no signal was detected. (3)TRAP negative samples gave no signals. (4)Specific indirect in-situ PCR was done. (5)HL60 cells showed down-regulation of telomerase activity after differentiation by VD3 and PHA-stimulated lymphocytes showed up-regulation of telomerase activity. (6)In artificial cell mixtures, there was an approximate correlation between the expected and observed number of positive cells.
This indirect method greatly increases the specificity of in situ PCR and enables the simultaneous observation of cell morphology and telomerase activity and could be used to detect minimal residual diseases.

Report

(5 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (30 results)

All Other

All Publications (30 results)

  • [Publications] Nakatake, M., Sasaki, N., Murakami Murofushi, K, Yamada, Q.: "Transient post-translational up-regulation of telomerase activity during megakaryocytic differentiation of K562 cells"B.B.R.C.. 314. 1080-1085 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yamada, P., Akiyama, M.et al.: "Overexpression of telomerase confers a survival advantage through suppression of TRF1 gene expression while maintaining differentiation characteristics in K562 cells"Cell Transplantation. 12. 365-377 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sawada T., Yamada Q., et al.: "Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter specifically kills human pancreatic cancer cell line"Cancer Cell International. 2(1). 14-20 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akiyama M, Yamada O. et al.: "Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors."Cancer Letter. 178(2). 187-197 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yamada, O. et al.: "Killer T cell induction in patients with blastic NK cell lymphoma/leukaemia : implications for successful treatment, and possible therapeutic strategies"Br.J.Haematol. 113. 153-160 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 山田 修(小沢敬也 編著): "造血幹細胞-基礎から遺伝子治療・再生医療へ-"中外医学社. 8 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akiyama, M., Yamada, O, Hideshima, T., Yanagisawa, T., Yokoi, K., Fujisawa, K., Eto, Y., Yamada, H., Kenneth C.Anderson.: "TNFα induces rapid activation and nuclear translocation of telomerase in human lymphocytes"B.B.R.C.. 316. 528-532 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakatake, M., Sasaki, N., Murakami-Murofushi, K, Yamada, O.: "Transient post-translational up-regulation of telomerase activity during megakaryocytic differentiation of K562 cells"B.B.R.C.. 314. 1080-1085 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yamada, O., Akiyama, M., Kawauchi, K., Adachi, T., Yamada, H., Kanda, N., Aikawa, E.: "Overexpression of telomerase confers a survival advantage through suppression of TRF1 gene expression while maintaining differentiation characteristics in K562 cells"Cell Transplant. 12. 365-377 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kato, T., Kosaka, K., Kimura, M., Imamura, S., Yamada, O., Iwai, K., Ando, M., Joh, K., Kuroe, K., Ohtake, A., Takao, A., Momma, K., Matsuoka, R.: "Thrombocytopenia in patients with 22q11.2 deletion syndrome and its association with glycoprotein Ib-β."Genetics in Medicine. 5. 113-119 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sawada T, Yamada, O., Yoshimura N, Hatori K, Fuchinoue S, Teraoka S.: "Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line"Cancer Cell Int. 3. 14-21 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ujiyara, M., Nomura, K., Yamada, O., Shibata, N., Kobayashi, M., Takano, K.: "Granulocyte-Macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide anion : a study using a monocytic-differentiated HL60 subline."Free Radical Biology & Medicine. 31. 1396-1404 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Higaki, Y., Yamada, O., Okamura, T., Mizoguchi, H., Kawashima, M.: "Granzyme-B-Containing Lymphocyte Involvement in Epidermal Injury in Graft-versus-Host Disease."Dermatology. 202. 94-98 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yamada, O., Ichikawa, M., Okamoto, T., Park, T., Motoji, T., Mizoguchi, H, Shibuya, A.: "Killer T cell induction in patients with blastic NK cell lymphoma/leukaemia : implications for successful treatment, and possible therapeutic strategies."Br.J.Haematol.. 113. 153-160 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akiyama, M., Yamadam, O., Akita, S., Urashima, M., Yamada, J.H., Ohno, T., Mizoguchi, H., Eto, Y., Yamada, H.: "Ectopic expression of c-myc fails to overcome downregulation of telomerase activity induced by herbimycin A, but ectopic hTERT expression overcomes it."Leukemia. 14. 1260-1265 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akiyama, M., Asai, O., Kuraishi, Y., Urashima, M., Hoshi, Y., Sakamaki, H., Yabe, H., Furukawa, T., Yamada, O., Mizoguchi, H., Yamada, H.: "Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation."Bone Marrow Transplantation. 25. 441-447 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Akiyama M., Yamada O.et al.: "Telomerase overexpression in K562 leukemia cells protects against by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors."Cancer Letter. 178(2). 187-197 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Sawada T., Yamada O, et al.: "Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter specifically kills human pancreatic cancer cell line"Cancer Cell International. 2(1). 14-20 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamada, O., Akiyama, M.et al.: "Overexpression of telomerase confers a survival advantage through suppression of TRF1 gene expression while maintaining differentiation characteristics in K562 cells"Cell Transplantation. 12. 365-377 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nakatake, M., Sasaki, N., Murakami-Murofushi, K., Yamada, O.: "Transient post-translational up-regulation of telomerase activity during megakaryocytic differentiation of K562 cells"B.B.R.C.. 314. 1080-1085 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] 山田 修(小沢敬也 編著): "造血幹細胞-基礎から遺伝子治療・再生医療へ-"中外医学社. 8 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Akiyama M., Yamada O.et al.: "Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors"Cancer Letter. 178(2). 187-197 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sawada T., Yamada O, et al.: "Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter specifically kills human pancreatic cancer cell line"Cancer Cell International. 2(1). 14-20 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yamada, O., Akiyama, M.et al.: "Overexpression of telomerase confers a survival advantage through suppression of TRF1 gene expression while maintaining differentiation characteristics in K562 cells"Cell Transplantation. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] 山田 修(小沢敬也編著): "造血幹細胞-基礎から遺伝子治療・再生医療へ-"中外医学社. 8 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ujihara, M: "Granulocyte-macrophage colony-stimulating factor ensures macrophage survival and generation of the superoxide union : a study using a monocyte-differentiated HLCO subline"Free Radical Biology & Medicine. 31. 1396-1404 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Higaki, Y: "Granzyme-B-Containing Lymphocyte linvolvement in Epidermal Injury in Graft-versus-Host Bisease"Dermatology. 202. 94-98 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamada, O: "Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukemia : implication for successful treatment and possible therapeatic strategies"British Journal of Haematology. 113. 153-160 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 山田修: "CTLを誘導したBlastic NK cell lymphomaの2例"血液・腫瘍科. 41. 294-296 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamada,O et al: "Killer T cell induction in patients with blastic NK cell lymphoma/leukemia"Br.J.Haematol. (in press). (2001)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi